BIOTIME INC·4

Jul 3, 6:22 PM ET

Mulroy Michael H. 4

4 · BIOTIME INC · Filed Jul 3, 2018

Insider Transaction Report

Form 4
Period: 2018-07-01
Transactions
  • Award

    Option to Purchase Common Shares

    2018-07-01+40,00040,000 total
    Exercise: $2.06Exp: 2023-06-30Common Shares (40,000 underlying)
Holdings
  • Option to Purchase Common Shares

    Exercise: $3.29Exp: 2019-10-03Common Shares (20,000 underlying)
    20,000
  • Option to Purchase Common Shares

    Exercise: $3.15Exp: 2022-06-30Common Shares (20,000 underlying)
    20,000
  • Option to Purchase Common Shares

    Exercise: $2.72Exp: 2021-06-30Common Shares (20,000 underlying)
    20,000
  • Common Shares, no par value

    32,550
  • Option to Purchase Common Shares

    Exercise: $3.57Exp: 2020-06-30Common Shares (20,000 underlying)
    20,000
Footnotes (5)
  • [F1]Will become exercisable on June 30, 2019, based upon continued service on the board of directors.
  • [F2]Became exercisable in four equal quarterly installments after the date of grant on July 1, 2017.
  • [F3]Became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.
  • [F4]Became exercisable in four equal quarterly installments after the date of grant on July 1, 2015.
  • [F5]Became exercisable in four equal quarterly installments after the date of grant on October 4, 2014.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION